CCO Treatment Updates

The Clinical Impact of Next-Generation NNRTIs: Recent Research and Practical Treatment Strategies

Questions And Answers

Review the answers to Clinical Care Options member questions on next-generation NNRTIs posted by our expert faculty. If you do not find what you are looking for, you can submit your own question.

 


The Next Generation of NNRTIs

Module 1 of 1

Faculty:

Anton L. Pozniak, MD, FRCP
  • Anton L. Pozniak, MD, FRCP

CME CREDIT INFORMATION

Release Date: 09/14/07

Expiration Date: 09/13/08


Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the Module

Anton L. Pozniak, MD, FRCP, discusses the need for novel next-generation of NNRTIs, the future of this drug class, and current NNRTIs in clinical development.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the strengths and limitations of the first-generation NNRTIs
  • Discuss data from randomized clinical trials investigating next-generation NNRTIs
  • Describe next-generation NNRTIs in early clinical and preclinical development

Virtual Presentations

The Clinical Need for Next-Generation NNRTIs

Faculty:

Eric S. Daar, MD
  • Eric S. Daar, MD

CME CREDIT INFORMATION

Release Date: 07/13/07

Expiration Date: 07/12/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the Virtual Presentation

Eric S. Daar, MD, reviews data from clinical trials that highlight the strengths and weaknesses of the currently available NNRTIs and discusses the clinical need for a next generation of NNRTIs.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recall data from clinical trials highlighting the strengths and weaknesses of the currently approved NNRTIs
  • Describe how transmitted NNRTI resistance mutations could influence treatment outcomes
  • Discuss the potential clinical benefit of next-generation NNRTIs

The Clinical Need for Next-Generation NNRTIs


Format: Microsoft PowerPoint (.ppt) | File size: 936 KB


The Potential Clinical Impact of Next-Generation NNRTIs

Faculty:

Joseph J. Eron, Jr., MD
  • Joseph J. Eron, Jr., MD

CME CREDIT INFORMATION

Release Date: 09/05/07

Expiration Date: 09/04/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the Virtual Presentation

Joseph J. Eron, Jr., MD, discusses the potential impact of next-generation NNRTIs on the management of HIV-infected patients based on the results of clinical trials.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recall the clinical strengths and weaknesses of the first-generation NNRTIs
  • Describe data from clinical trials investigating next-generation NNRTIs
  • Discuss the potential clinical applications of the next-generation NNRTIs

The Potential Clinical Impact of Next-Generation NNRTIs


Format: Microsoft PowerPoint (.ppt) | File size: 1.03 MB


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.

Have a Question on NNRTIs?

Submit your question to our expert faculty

   
Copy me on this submission.